P_糖蛋白抑制剂的研究进展.pdfVIP

20 11 4 25 2 Pract G eriatr, A p ri 20 11, V o . 25, N o. 2 165 tery, 2010, 21( 3) : 129136. eve s in hea thy e der y subjects to o , 2007, 49 ( 24) : 2364. [ 16] M euw eseM C, Stroes ESG, H azen SL, pred ict risk o f deve oping heart fai [ 21] M ichow itz Y, K isi S, GuznerG ur et a. Serum mye operox idase eve s ure[ J] . Am J Card io , 2009, 10 3 H, et a. U sefu ness o f serum are associated w ith the future risk o f ( 9) : mye operox idase in pred ic tion o f mo r coronary artery d isease in apparent y [ 19] T ang W, B rennan M, Ph i ip K. ta ity in patients w ith severe heart hea thy ind iv idua s the EP ICN orfo k P asma m ye operox idase eve s in pa fa iure[ J] . Isr M ed A ssoc J, 200 8, prospective popu ation study [ J ] . tients w ith chronic systo ic hea rt fai 10 ( 12) : 884888. JACC, 2007, 50 ( 2) : 159165. ure [ J] . Am J Card io , 2006, 9 8 [ 22] N g LL, Pa th ik B, L oke IW, et a. [ 17] W ang ND, G ransar H, N a ru a J, et ( 6) : 796799. M ye operox idase and Creac tive pro a. M ye operox idase, subc in ica ath [ 20] T ang W, T ong W, T roughton RW, te in augm ent the spec if ic ity of Btype erosc ero sis, and card iovascu ar dis et a . P rognostic va ue and echo natr iuretic peptide in comm un ity ease events [ J ] . JACC Cardiovasc ca rdiographic de term inants o f p asm a screen ing for sy sto ic heart fa i ure Im ag ing, 2009, 2( 9) : m ye operox idase eve s in chron ic [ J] . Am H eart J, 2006, 152 ( 1) : [ 18] T ang W H, K atz R, B rennan M L, et heart fai ure [ J] . J Am Co C ard i 94101. a. U se fu ness of mye operox idase (收稿日期: 20 100816 ) P [ ] R 9791 [ ] A do i: 10. 3969 / j. issn. 2011. 02. 023 , 2 , , P